Inguinoscrotal Sarcoma Treatment in London

Have you or a loved one been diagnosed with an inguinoscrotal or paratesticular mass? These rare malignancies require highly specialised care to achieve the best surgical and oncological outcomes.

At Harley Street Andrology, we offer expert diagnostics and a multidisciplinary approach to managing inguinoscrotal sarcoma, helping patients in London and across the UK navigate this complex diagnosis. Led by Professor Asif Muneer, a globally recognised urological surgeon and andrologist, our clinic provides world-class care tailored to the management of these rare soft-tissue tumours.

Rare Scrotal Swellings and Paratesticular Lesions

Not all scrotal lumps are related to the testis itself. Rare scrotal swellings can often be attributed to paratesticular lesions, which arise from the surrounding tissues such as the spermatic cord, epididymis, or tunica vaginalis.

Due to their complex nature and the potential for malignancy, these lesions require a high index of suspicion and specialised surgical management. Treatment typically involves a hemiscrotectomy (removal of the affected half of the scrotum) to ensure clear surgical margins and prevent recurrence.

This care is strictly coordinated with a dedicated sarcoma oncologist to ensure a comprehensive multidisciplinary treatment plan.

Inguinoscrotal Sarcomas

Inguinoscrotal sarcomas are rare and often present as paratesticular tumours.

We offer a complete service together with the oncology team at Leaders in Oncology for the management of these tumours.

Second opinions and revision surgery are carried out after joint multidisciplinary discussions and a dedicated pathology review.

Why Seek Treatment for Inguinoscrotal Sarcoma?

Inguinoscrotal sarcomas are exceedingly rare, but clinical data (such as the Froehner et al. meta-analysis) shows that with expert surgical intervention, the outlook is often positive:

• High Cure Rates: Approximately two-thirds of inguinoscrotal sarcomas can be successfully cured with appropriate treatment.
• Excellent Long-term Survival: In cases of low-grade tumours that are completely excised, 10-year survival rates can be as favourable as those for testicular germ cell tumours.
• Favourable Statistics: Meta-analysis data suggests 10-year disease-specific survival rates can range between 64% and 93% depending on the tumour grade.
• Specialised Management for Metastasis: Even in complex cases like rhabdomyosarcoma, durable control can be achieved through a combination of complete surgical resection, chemotherapy, and radiotherapy.

Note on Follow-up: Because these tumours can recur years later, we advocate for life-long surveillance to detect and manage any late recurrences early.

Advanced Diagnosis and Treatment

We provide state-of-the-art diagnostics and coordinate with tertiary sarcoma centres to ensure the highest standard of care for inguinoscrotal tumours.

Diagnosis

• Specialist Consultation: We review your symptoms and medical history, focusing on the specific characteristics of the scrotal or inguinal mass.
• Imaging: High-resolution MRI, CT, or ultrasound scans are used to assess the tumour size and involvement of the spermatic cord.
• Pathology Review: Given the rarity of these tumours, we ensure all cases undergo a specialist pathology review to confirm the exact subtype (e.g., liposarcoma, leiomyosarcoma, or rhabdomyosarcoma).

Treatment Options

Multimodal Therapy: In coordination with the oncology team, we facilitate adjuvant chemotherapy or radiotherapy when required by the tumour grade or subtype.

Primary Surgical Resection: The cornerstone of treatment is complete surgical removal with clear margins. This often requires a radical orchidectomy and, in many cases, a hemiscrotectomy.

Revision Surgery: We provide a dedicated service for patients who require further surgery following an initial incomplete excision elsewhere.

Cost of Sarcoma in London

Cost of treating Sarcoma at private clinics in London typically depends on the procedure and anaesthesia. Contact us for further details.

• Source (PubMed)